Sandostatin is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Octreotide Acetate.
| Product ID | 0078-0180_5b689d42-d065-4d77-be63-0d30a07deb89 |
| NDC | 0078-0180 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sandostatin |
| Generic Name | Octreotide Acetate |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
| Marketing Start Date | 1988-10-21 |
| Marketing Category | NDA / NDA |
| Application Number | NDA019667 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | OCTREOTIDE ACETATE |
| Active Ingredient Strength | 50 ug/mL |
| Pharm Classes | Somatostatin Analog [EPC],Somatostatin Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 1988-10-21 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA019667 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2012-08-13 |
| Marketing Category | NDA |
| Application Number | NDA019667 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1988-10-21 |
| Ingredient | Strength |
|---|---|
| OCTREOTIDE ACETATE | 50 ug/mL |
| SPL SET ID: | 4e2c9856-1836-49f0-9472-4dbeeb408f39 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0180 | Sandostatin | octreotide acetate |
| 0078-0181 | Sandostatin | octreotide acetate |
| 0078-0182 | Sandostatin | octreotide acetate |
| 0078-0183 | Sandostatin | octreotide acetate |
| 0078-0184 | Sandostatin | octreotide acetate |
| 0641-6174 | Octreotide Acetate | Octreotide Acetate |
| 0641-6175 | Octreotide Acetate | Octreotide Acetate |
| 0078-0647 | Sandostatin LAR Depot | octreotide acetate |
| 0078-0648 | Sandostatin LAR Depot | octreotide acetate |
| 0078-0811 | Sandostatin LAR Depot | octreotide acetate |
| 0078-0818 | Sandostatin LAR Depot | octreotide acetate |
| 0078-0825 | Sandostatin LAR Depot | octreotide acetate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() SANDOSTATIN 73572578 1412956 Live/Registered |
SANDOZ PHARMACEUTICALS CORPORATION 1985-12-09 |